Hepatitis E VirClia – fully automated solution for Hepatitis E serology

Last updated: 14th May, 2025

Fast | Precise | Automated

Elevate your diagnostic precision with the first commercial HEV avidity test, ensuring reliable confirmation of acute infections. Vircell’s comprehensive Hepatitis E solution including IgM, IgG, and IgG avidity assays delivers fast, precise, and automated results for confident detection.

A fully automated solution for Hepatitis E serology

  • Hepatitis E virus (HEV) is the most common cause of acute hepatitis in the world1.
  • Every year, there are an estimated 20 million HEV infections worldwide, leading to an estimated 3.3 million symptomatic cases of hepatitis E2.
  • WHO estimates that hepatitis E caused approximately 44,000 deaths in 2015 (accounting for 3.3% of the mortality due to viral hepatitis)2.
  • The virus is transmitted via the fecal-oral route, principally via contaminated water.
  • Hepatitis E is found worldwide, but the disease is most common in East and South Asia.

Vircell offers a fully automated solution for Hepatitis E serology on the VirClia instruments:

  • Hepatitis E IgG Avidity Monotest
  • Hepatitis E IgG Monotest
  • Hepatitis E IgM Monotest


The Vircell Hepatitis E VirClia IgM, IgG, and IgG avidity assays offer several advantages for detecting Hepatitis E virus (HEV) antibodies:

  • Comprehensive detection – Covers IgM for acute infections, IgG for past exposure, and IgG avidity to distinguish recent from past infections.
  • Fast results – Provides results within 1 hour, making it ideal for urgent samples.
  • Monotest format – Each test includes a calibrator and negative control, ensuring accurate validation.
  • Automated and simple protocol – Works with primary sample tubes, reducing manual handling.
  • High sensitivity and specificity – Delivers reliable detection of HEV antibodies.
  • First commercial avidity test – Helps confirm acute Hepatitis E infections, improving diagnostic accuracy.
  • No need to batch samples

Reference   Class Content
VCM066 HEPATITIS E VIRCLIA IgG MONOTEST (quantitative) CE0123 24 tests
VCM067 HEPATITIS E VIRCLIA IgM MONOTEST (capture) CE 24 tests
VCM093 HEPATITIS E VIRCLIA IgG AVIDITY MONOTEST CE0123 12 tests

A study in Madrid, Spain confirmed the Vircell Hepatitis E method is a reliable serological method for the screening of acute infection in HEV clinical specimens.  View the poster here.


Find out more about Hepatitis E VirClia

View Flyer >


Find out more about Vircell VirClia Lotus Instrument

Click here >

View the Vircell 2025 Catalogues

Click here >

References:

1. https://www.who.int/news-room/fact-sheets/detail/hepatitis-E

2. https://aho.org/fact-sheets/hepatitis-e-fact-sheet/

THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.



Request a Quote

Request Quote

Go BackGo Back
Top
Abacus dx